SHARPS TECHNOLOGY INC (STSS) Stock Overview
USA - NASDAQ:STSS - US82003F3091 - Common Stock
STSS Key Statistics, Chart & Performance
The current stock price of STSS is 4.72 USD. In the past month the price decreased by -42.16%. In the past year, price decreased by -99.46%.
STSS Latest News, Press Relases and Analysis
STSS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 24.87 | 37.53B | ||
| COO | COOPER COS INC/THE | 17.9 | 14.31B | ||
| SOLV | SOLVENTUM CORP | 11.87 | 12.51B | ||
| ALGN | ALIGN TECHNOLOGY INC | 13.86 | 9.46B | ||
| BLCO | BAUSCH + LOMB CORP | 35.71 | 5.31B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 22.37 | 4.85B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.7 | 3.78B | ||
| ICUI | ICU MEDICAL INC | 15.75 | 2.92B | ||
| XRAY | DENTSPLY SIRONA INC | 7.32 | 2.50B | ||
| HAE | HAEMONETICS CORP/MASS | 10.81 | 2.42B | ||
| UFPT | UFP TECHNOLOGIES INC | 22.66 | 1.51B | ||
| ESTA | ESTABLISHMENT LABS HOLDINGS | N/A | 1.37B |
Related stock screener links
About STSS
Company Profile
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York and currently employs 5 full-time employees. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Company Info
SHARPS TECHNOLOGY INC
105 Maxess Road, Ste. 124
Melville NEW YORK US
Employees: 5
Phone: 15162464000
SHARPS TECHNOLOGY INC / STSS FAQ
What is the stock price of SHARPS TECHNOLOGY INC today?
The current stock price of STSS is 4.72 USD. The price decreased by -6.72% in the last trading session.
What is the ticker symbol for SHARPS TECHNOLOGY INC stock?
The exchange symbol of SHARPS TECHNOLOGY INC is STSS and it is listed on the Nasdaq exchange.
On which exchange is STSS stock listed?
STSS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SHARPS TECHNOLOGY INC stock?
7 analysts have analysed STSS and the average price target is 22.44 USD. This implies a price increase of 375.42% is expected in the next year compared to the current price of 4.72. Check the SHARPS TECHNOLOGY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SHARPS TECHNOLOGY INC worth?
SHARPS TECHNOLOGY INC (STSS) has a market capitalization of 125.55M USD. This makes STSS a Micro Cap stock.
How many employees does SHARPS TECHNOLOGY INC have?
SHARPS TECHNOLOGY INC (STSS) currently has 5 employees.
Is SHARPS TECHNOLOGY INC (STSS) expected to grow?
The Revenue of SHARPS TECHNOLOGY INC (STSS) is expected to decline by -95.06% in the next year. Check the estimates tab for more information on the STSS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SHARPS TECHNOLOGY INC (STSS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of STSS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of STSS, evaluating the profitability, health, valuation and growth aspects
- SHARPS TECHNOLOGY INC (STSS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SHARPS TECHNOLOGY INC (STSS) Sales and EPS estimates to see what analysts future expectations are.
- SHARPS TECHNOLOGY INC (STSS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SHARPS TECHNOLOGY INC (STSS) Insider and Institutional Ownership to learn about the owners and their transactions.
- SHARPS TECHNOLOGY INC (STSS) Stock Chart to make your own analysis
- SHARPS TECHNOLOGY INC (STSS) Latest news and press-releases to stay up to date.
Does SHARPS TECHNOLOGY INC (STSS) stock pay dividends?
STSS does not pay a dividend.
What is the Price/Earnings (PE) ratio of SHARPS TECHNOLOGY INC (STSS)?
SHARPS TECHNOLOGY INC (STSS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1065.01).
What is the Short Interest ratio of SHARPS TECHNOLOGY INC (STSS) stock?
The outstanding short interest for SHARPS TECHNOLOGY INC (STSS) is 1.25% of its float. Check the ownership tab for more information on the STSS short interest.
STSS Technical Analysis
STSS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to STSS. No worries on liquidiy or solvency for STSS as it has an excellent financial health rating, but there are worries on the profitability.
STSS Financial Highlights
Over the last trailing twelve months STSS reported a non-GAAP Earnings per Share(EPS) of -1065.01. The EPS increased by 67.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.23% | ||
| ROE | -4.97% | ||
| Debt/Equity | 0 |
STSS Forecast & Estimates
7 analysts have analysed STSS and the average price target is 22.44 USD. This implies a price increase of 375.42% is expected in the next year compared to the current price of 4.72.
For the next year, analysts expect an EPS growth of -633.33% and a revenue growth -95.06% for STSS